Chicago, IL—Real-world patients with mitral regurgitation (MR) not meeting the COAPT eligibility criteria who ultimately underwent clip-based transcatheter mitral valve repair fared just as well as ...

NEW YORK, NY—More postmarket registry data confirm the safety and efficacy of mitral transcatheter edge-to-edge repair (M-TEER) with MitraClip (Abbott) in patients with secondary mitral regurgitation ...

Fewer than one in five patients enrolled in the COAPT trial of the MitraClip (Abbott) were “super-responders” to their assigned therapies, with more seen in the percutaneous intervention group than in ...

Edge-to-edge transcatheter mitral valve repair with the MitraClip (Abbott) in heart failure patients with secondary mitral regurgitation (MR) lowers the risk of death or heart failure-related ...

SAN DIEGO, CA (UPDATED)—It’s a shocking success for the MitraClip after years of gloomy predictions, sluggish trial enrollment, and—most of all—the negative MITRA-FR trial results last month. Today, ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Patients with HF with moderate to severe or severe functional mitral regurgitation who underwent ...

SAN DIEGO, CA (UPDATED)—I felt a pang of sympathy for 26 of the 27 “late-breaking” studies presented this year at TCT. In the lead-up to the meeting, rumors were rampant that COAPT was “different” ...

ATHENS, Greece—New data from the COAPT trial indicate that MitraClip therapy for functional mitral regurgitation (FMR) improves outcomes as compared with guideline-directed medical therapy (GDMT) ...

ATHENS, Greece—Heart failure experts gathered here at the European Society of Cardiology 2019 Heart Failure (ESC HF) Congress saw several new COAPT analyses and seemed at least partly reassured that ...

Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS —Two substudies from the COAPT trial presented at the American College of Cardiology Scientific ...